
Insilico Medicine receives IND approval for novel AI-designed USP1 inhibitor for cancer
Insilico Medicine receives IND approval for novel AI-designed USP1 inhibitor for cancer Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical stage drug discovery company, announced that the U.S. Food…











